Influence of mtDNA genetic variation on antibiotic therapy
- 1 September 2010
- journal article
- Published by Future Medicine Ltd in Pharmacogenomics
- Vol. 11 (9), 1185-1187
- https://doi.org/10.2217/pgs.10.115
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Mitochondrial DNA mutations and human diseaseBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Mitochondrial pharmacogenomics: barcode for antibiotic therapyDrug Discovery Today, 2010
- Antibiotic effects on mitochondrial translation and in patients with mitochondrial translational defectsMitochondrion, 2009
- Prevalence of Mitochondrial 1555A→G Mutation in Adults of European DescentNew England Journal of Medicine, 2009
- Prevalence of Mitochondrial 1555A→G Mutation in European ChildrenNew England Journal of Medicine, 2009
- Back to the Future: The Ribosome as an Antibiotic TargetFuture Microbiology, 2007
- Population prevalence of the MELAS A3243G mutationMitochondrion, 2007
- Erythromycin as a potential precipitating agent in the onset of Leber's hereditary optic neuropathyMitochondrion, 2004
- The A1555G Mutation in the 12S rRNA Gene of Human mtDNA: Recurrent Origins and Founder Events in Families Affected by Sensorineural DeafnessAmerican Journal of Human Genetics, 1999
- Mitochondrial EvolutionScience, 1999